Curatis Holding AG (CHIX:CURNZ) Accounts Payable & Accrued Expense : CHF1.09 Mil (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG Accounts Payable & Accrued Expense?

Curatis Holding AG's quarterly accounts payable & accrued expense declined from Jun. 2023 (CHF0.11 Mil) to Dec. 2023 (CHF0.04 Mil) but then increased from Dec. 2023 (CHF0.04 Mil) to Jun. 2024 (CHF1.09 Mil).

Curatis Holding AG's annual accounts payable & accrued expense increased from Dec. 2021 (CHF0.09 Mil) to Dec. 2022 (CHF0.19 Mil) but then declined from Dec. 2022 (CHF0.19 Mil) to Dec. 2023 (CHF0.04 Mil).

Curatis Holding AG Accounts Payable & Accrued Expense Historical Data

The historical data trend for Curatis Holding AG's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Accounts Payable & Accrued Expense Chart

Curatis Holding AG Annual Data

Trend

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

0.09

0.19

0.04

Curatis Holding AG Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			0.41	0.19	0.11	0.04	1.09

Curatis Holding AG Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Curatis Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

26U:Germany CURN:Switzerland

Address

Weierweg 7, Liestal, CHE, CH-4410

Website

https://www.curatis.com

Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.

Curatis Holding AG Headlines

No Headlines